Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype

British Journal of Cancer

Volumn 99, Issue 10, 2008, Pages 1735-1742

  Van Der Auwera, I ^a,b   Van Laere, S J ^a,b   Van Den Bosch, S M ^c   Van Den Eynden, G G ^a,b   Trinh, B X ^a,b   Van Dam, P A ^a,b   Colpaert, C G ^a,b   Van Engeland, M ^c   Van Marck, E A ^a,b   Vermeulen, P B ^a,b   Dirix, L Y ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b SINT AUGUSTINUS HOSPITAL   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

APC; Inflammatory breast cancer; Laser microdissection; Methylation; Methylation specific PCR

Indexed keywords

APC PROTEIN; MESSENGER RNA;

ADULT; AGED; APC GENE; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; DNA METHYLATION; FEMALE; GENES, APC; HUMANS; INFLAMMATION; MIDDLE AGED; PHENOTYPE; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 55949118381     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604705     Document Type: Article

References (50)

1. Aggerholm A, Hokland P (2000) DAP-kinase CpG island methylation in acute myeloid leukemia: methodology vs biology? Blood 95: 2997-2999
2. Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Nasser V, Loriod B, Camerlo J, Tagett R, Tarpin C, Houvenaeghel G, Nguyen C, Maraninchi D, Jacquemier J, Houlgatte R, Birnbaum D, Viens P (2004) Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res 64: 8558-8565
3. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377
4. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJ, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scambler P (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328: 614-616
5. Brakensiek K, Langer F, Kreipe H, Lehmann U (2004) Low level of DAP-kinase DNA methylation in myelodysplastic syndrome. Blood 104: 1586-1587
6. Chen YL, Xie YT, Wen XZ, Deng DJ (2007) Aberrant methylation of APC and Bikunin CpG islands in sporadic breast carcinomas. Zhonghua Yu Fang Yi Xue Za Zhi 41(Suppl): 17-19
7. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS (1996) Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059
8. Dirix LY, Dam PV, Prove A, Vermeulen PB (2006) Inflammatory breast cancer: current understanding. Curr Opin Oncol 18: 563-571
9. Dulaimi E, Hillinck J, de Caceres II, Al Saleem T, Cairns P (2004a) Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 10: 6189-6193
10. Dulaimi E, Hillinck J, de Caceres II, Al Saleem T, Cairns P (2004b) Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 10: 6189-6193
11. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucl Acids Res 28: e32
12. Elston CW (1984) The assessment of histological differentiation in breast cancer. Aust N Z J Surg 54: 11-15
13. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG (2000) Analysis of adenomatous polyposis coll promoter hypermethylation in human cancer. Cancer Res 60: 4366-4371
14. Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10: 721-733
15. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
16. Furuuchi K, Tada M, Yamada H, Kataoka A, Furuuchi N, Hamada J, Takahashi M, Todo S, Moriuchi T (2000) Somatic mutations of the APC gene in primary breast cancers. Am J Pathol 156: 1997-2005
17. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600
18. Ho KY, Kalle WH, Lo TH, Lam WY, Tang CM (1999) Reduced expression of APC and DCC gene protein in breast cancer. Histopathology 35: 249-256
19. House MG, Guo M, Iacobuzio-Donahue C, Herman JG (2003) Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis 24: 193-198
20. Issa JP (2000) CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 249: 101-118
21. Jin Z, Tamura G, Tsuchiya T, Sakata K, Kashiwaba M, Osakabe M, Motoyama T (2001) Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer 85: 69-73
22. Jonsson M, Borg A, Nilbert M, Andersson T (2000) Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer. Eur J Cancer 36: 242-248
23. Joslyn G, Carlson M, Thliveris A, Albertsen H, Gelbert L, Samowitz W, Groden J, Stevens J, Spirio L, Robertson M (1991) Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66: 601-613
24. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D (1991) Identification of FAP locus genes from chromosome 5q21. Science 253: 661-665
25. Lee A, Kim Y, Han K, Kang CS, Jeon HM, Shim SI (2004) Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast. Arch Pathol Lab Med 128: 1251-1256
26. Lerebours F, Bieche I, Lidereau R (2005) Update on inflammatory breast cancer. Breast Cancer Res 7: 52-58
27. Liu Z, Yang L, Cui DX, Liu BL, Zhang XB, Ma WF, Zhang Q (2007) Methylation status and protein expression of adenomatous polyposis coli (APC) gene in breast cancer. Ai Zheng 26: 586-590
28. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408
29. Medeiros AC, Nagai MA, Neto MM, Brentani RR (1994) Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas. Cancer Epidemiol Biomarkers Prev 3: 331-333
30. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T, Nakamura Y (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1: 229-233
31. Muller HM, Fiegl H, Widschwendter A, Widschwendter M (2004) Prognostic DNA methylation marker in serum of cancer patients. Ann N Y Acad Sci 1022: 44-49
32. Muller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, Perkmann E, Marth C, Widschwendter M (2003) DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 63: 7641-7645
33. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669
34. Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ, Laird PW, Loda M, Fuchs CS (2006) Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 8: 209-217
35. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60: 5954-5958
36. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237
37. Roa JC, Anabalon L, Tapia O, Martinez J, Araya JC, Villaseca M, Guzman P, Roa I (2004) Promoter methylation profile in breast cancer. Rev Med Chil 132: 1069-1077
38. Schlosshauer PW, Brown SA, Eisinger K, Yan Q, Guglielminetti ER, Parsons R, Ellenson LH, Kitajewski J (2000) APC truncation and increased beta-catenin levels in a human breast cancer cell line. Carcinogenesis 21: 1453-1456
39. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20: 3628-3636
40. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963-968
41. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130-1134
42. Thompson AM, Morris RG, Wallace M, Wyllie AH, Steel CM, Carter DC (1993) Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68: 64-68
43. Turker MS (2002) Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 21: 5388-5393
44. Usadel H, Brabender J, Danenberg KD, Jeronimo C, Harden S, Engles J, Danenberg PV, Yang S, Sidransky D (2002) Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 62: 371-375
45. Ushijima T (2005) Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5: 223-231
46. Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY (2004) Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by realtime reverse transcriptase-PCR gene expression quantification. Clin Cancer Res 10: 7965-7971
47. Van Laere S, Van der Auwera I, Van den Eynden G, Van Hummelen P, van Dam P, Van Marck E, Vermeulen PB, Dirix L (2007) Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis. Br J Cancer 97: 1165-1174
48. Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, van Dam P, van Marck EA, Vermeulen PB, Dirix LY (2005) Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis. Breast Cancer Res Treat 93: 237-246
49. Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF (2001) Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res 7: 1998-2004
50. Yan PS, Venkataramu C, Ibrahim A, Liu JC, Shen RZ, Diaz NM, Centeno B, Weber F, Leu YW, Shapiro CL, Eng C, Yeatman TJ, Huang THM (2006) Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res 12: 6626-6636